BUSHWICK — NYC HEALTH + HOSPITALS/WOODHULL HAS BEEN NAMED A CENTER OF EXCELLENCE IN LUNG CANCER SCREENING by GO2 for Lung Cancer, a non-profit organization serving the community of patients facing that disease. The award was given for Woodhull’s ongoing commitment to providing the North Brooklyn community with patient-centered, evidence-based lung cancer screening.
Most of the estimated 237,000 Americans diagnosed annually with lung cancer are found at an advanced stage of the disease. As a result, lung cancer has long been the leading cause of cancer deaths in the U.S. By screening individuals at high risk for lung cancer using low-dose computed tomography, this disease can now be found early, when it is most treatable and even curable.
GO2 Centers of Excellence designated in lung cancer screening are committed to the principles of patient-centered communication and decision making across the entire care pathway. They implement screening in accordance with current evidence and clinical guidelines that professional bodies such as the American College of Radiology and the National Comprehensive Cancer Network have developed. They coordinate patient follow-up, diagnostics, and transition to treatment through a multidisciplinary clinical process.
Individuals and referring providers can learn more about lung cancer screening eligibility and appointments by calling 1-844-NYC-4NYC or visiting nychealthandhospitals.org/woodhull.
✰✰✰
